GlassScriptPhysician profile
Jeffrey A Genaw
NPI 1881725679
$14,480.91
in general payments reported to CMS, 2019-2025
7 companies · $1,240 in 2025
The $1,240 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $7,699 · 2021: $3,106 · 2022: $389 · 2023: $1,619 · 2024: $239 · 2025: $1,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,608 · Food and Beverage: $1,456 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,607.52 |
| Food and Beverage | $1,455.79 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,513.27 | 2020-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $735.23 | 2019-2023 | Seamguard, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Lightforce Orthodontics, INC. | $76.81 | 2023 | |
| Heron Therapeutics, INC. | $71.13 | 2022-2024 | Zynrelef, Aponvie |
| Covidien LP | $55.27 | 2019 | |
| Baxter Healthcare | $17.45 | 2020 | |
| Ethicon US, LLC | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Genaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.